Technical Analysis for CTX - Crescita Therapeutics Inc.

Grade Last Price % Change Price Change
D 0.580 -1.69% -0.010
CTX closed down 1.69 percent on Friday, November 1, 2024, on 22 percent of normal volume.
Earnings due: Nov 6
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Crossed Above 20 DMA Bullish -1.69%
Volume Surge Other -1.69%
Bollinger Band Squeeze Range Contraction -1.69%
Narrow Range Bar Range Contraction -1.69%
Volume Surge Other -1.69%
Bollinger Band Squeeze Range Contraction -1.69%
Narrow Range Bar Range Contraction -1.69%
Gapped Down Weakness -1.69%

   Recent Intraday Alerts

Alert Time
Fell Below Previous Day's Low about 22 hours ago
Down 1% about 22 hours ago
Fell Below 20 DMA about 22 hours ago
3x Volume Pace 2 days ago
2x Volume Pace 2 days ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Crescita Therapeutics Inc. Description

Crescita Therapeutics Inc. is a drug development company. The Company owns products for treating medical conditions in dermatology and pain. It owns various drug delivery platforms, which include Durapeel and Foam technology to support the development of patented formulations that can deliver actives into or through the skin. It operates two business units: the Topical Products and Technology (TPT) Group and the Immunology Group. The TPT Group product, Pliaglis and other products are focused on dermatology and pain. Its product Flexicaine is in Phase II clinical stage and has therapeutic area in Tick-borne disease. Its product Ibuprofen Foam is in pre-clinical stage and has therapeutic area in Acute Pain. Its product Terbinafine is in pre-clinical stage and has therapeutic area in Onychomycosis. Its product Mical 1 is in pre-clinical stage and has therapeutic area in Psoriasis. Its product Mical 2 is in pre-clinical stage and has therapeutic area in Dermatological skin treatment.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Delivery Clinic Drug Pain Disease RTT Medical Specialties Skin Drugs Organ Systems Drug Development Immunology Psoriasis Dermatology Acute Pain Drug Delivery Onychomycosis Topical Products

Is CTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.73
52 Week Low 0.36
Average Volume 23,831
200-Day Moving Average 0.505
50-Day Moving Average 0.613
20-Day Moving Average 0.589
10-Day Moving Average 0.597
Average True Range 0.012
RSI (14) 44.13
ADX 17.52
+DI 27.069
-DI 46.422
Chandelier Exit (Long, 3 ATRs) 0.586
Chandelier Exit (Short, 3 ATRs) 0.595
Upper Bollinger Bands 0.620
Lower Bollinger Band 0.557
Percent B (%b) 0.37
BandWidth 10.807
MACD Line -0.003
MACD Signal Line -0.004
MACD Histogram 0.0007
Fundamentals Value
Market Cap 11.98 Million
Num Shares 20.6 Million
EPS 0.01
Price-to-Earnings (P/E) Ratio 82.86
Price-to-Sales 1.08
Price-to-Book 0.77
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.595
Resistance 3 (R3) 0.597 0.593 0.593
Resistance 2 (R2) 0.593 0.590 0.593 0.592
Resistance 1 (R1) 0.587 0.587 0.585 0.585 0.591
Pivot Point 0.583 0.583 0.583 0.583 0.583
Support 1 (S1) 0.577 0.580 0.575 0.575 0.569
Support 2 (S2) 0.573 0.577 0.573 0.568
Support 3 (S3) 0.567 0.573 0.568
Support 4 (S4) 0.565